MedPath

Mandibular Advancement Device on Sleep Quality in Obstructive Sleep Apnea Patients

Active, not recruiting
Conditions
Sleep Apnea, Obstructive
Registration Number
NCT06169228
Lead Sponsor
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Brief Summary

Sleep is an important factor that influences long-term quality of life with known health consequences. Obstructive sleep apnea, the most prevalent disease that disturbs sleep, is considered a public health problem. Treatment with continuous positive airway pressure is cost effective and reverses the clinical consequences but there is a percentage of patients who do not tolerate it or leave it without treatment and with potential future health complications. Mandibular advancement device can be a valid and well tolerated alternative, it is known that it reduces apnea-hypopnea index, but its effect on the improvement of sleep quality is evaluated by polysomnography that interferes with the quality of sleep. There is an ambulatory monitoring device for sleep quality and circadian rhythms, which can register prolonged periods of time, under natural conditions and at a lower cost than a polysomnography. This pilot project assesses whether mandibular advancement device is an effective and well tolerated alternative in the treatment of obstructive sleep apnea to improve the quality of life and sleep in the medium and long term.

Detailed Description

Design: observational, unicentric prospective. 50 patients / year will be included, for 3 years. The care protocol (evaluation and follow-up) of the multidisciplinary sleep unit will be followed. Demographic and anthropometric data will be collected. The dental status of the temporo-mandibular joint will be assessed. Radiological records, home respiratory polygraphy, ambulatory monitoring device for 7 days , quality of life questionnaires before and after treatment.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Diagnosis of Obstructive Sleep Apnea Syndrome
  • opt for mandibular advancement device as 1st treatment alternative
  • opt for mandibular advancement device due to intolerance to continuous positive airway pressure
Exclusion Criteria
  • Patient with orthodontics, malocclusion and periodontal or temporomandibular joint disease who, after assessment by dentistry contraindicates it.
  • Central Sleep apnea (more than 50% of central events in the baseline polygraph).
  • Under 18 years old.
  • Pregnancy
  • Comorbidities that can potentially alter sleep architecture.
  • Psychophysical inability to complete questionnaires.
  • Not obtaining informed consent.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
mandibular advancement device on sleep quality3 years

Tolerability and efficacy of treatment with a mandibular advancement device (MAD) on sleep quality in patients with Obstructive Sleep Apnea (OSA) measured by the ambulatory circadian monitoring device.

ambulatory circadian monitoring device3 years

To evaluate improvement in sleep quality with mandibular advancement devices measured by fragmentation and stability of sleep by the circadian monitoring sensor.

home sleep apnea test3 years

To evaluate the number of residual apneic breaths measured by home home sleep apnea test

Secondary Outcome Measures
NameTimeMethod
questionnaire EuroQoL3 years

standardized non-disease specific instrument to describe and value health-related quality of life

questionnaire iPAQ3 years

International Physical Activity Questionnaire

Obstructive sleep apnea severity3 years

Evaluate the severity by home sleep apnea test

questionnaire SF-123 years

multidimensional health related quality of life

Trial Locations

Locations (1)

Maria Fernanda Troncoso Acevedo

🇪🇸

Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath